The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Feasibility of implementing a pharmacist-led DPYD gene testing service for patients commencing 5-fluorouracil (5FU) or capecitabine.
 
Benjamin Lee
No Relationships to Disclose
 
Sarah Glewis
No Relationships to Disclose
 
Marliese Alexander
Consulting or Advisory Role - Bristol-Myers Squibb/Pfizer
Travel, Accommodations, Expenses - Roche Molecular Diagnostics
 
Danny Rischin
Research Funding - Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Kura Oncology (Inst); Merck (Inst); Merck KGaA (Inst); Regeneron (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - GlaxoSmithKline; Merck
(OPTIONAL) Uncompensated Relationships - GlaxoSmithKline; Merck; Regeneron; Sanofi
 
Prudence A. Francis
Honoraria - AstraZeneca; Novartis; Novartis
Travel, Accommodations, Expenses - Ipsen; Novartis
 
Michael Jefford
Travel, Accommodations, Expenses - Roche
 
Hui-Li Wong
Stock and Other Ownership Interests - Oncosil (I)
Research Funding - Roche (Inst)
Travel, Accommodations, Expenses - Roche
 
Jeanne Tie
Honoraria - Amgen; FivepHusion; Inivata; Merck Serono; SERVIER
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; Merck Serono; Pierre Fabre
 
Michael Michael
Consulting or Advisory Role - Ipsen; Isotopen Technologien; Merck
Research Funding - Ipsen
Travel, Accommodations, Expenses - Novartis
 
Senthil Lingaratnam
No Relationships to Disclose